Over 10-Year Outcomes of Infantile-Onset Epilepsies

Hyun-Jin Kim1, Han Na Jang2, Hyunji Ahn2

  • 1Department of Pediatrics, Myongji Hospital, Goyang 10475, Korea.

Insights

Infantile-onset epilepsy often shows variable outcomes, with many experiencing remission. However, some cases involve intractable seizures and developmental issues, highlighting the need for timely diagnosis and treatment.

Area of Science:

  • Pediatric Neurology
  • Epileptology
  • Clinical Neuroscience

Background:

  • Infantile-onset epilepsy presents diverse clinical courses and etiologies.
  • Long-term follow-up studies on infantile epilepsy are limited.
  • Understanding long-term outcomes is crucial for management.

Purpose of the Study:

  • To analyze clinical courses and seizure outcomes of infantile-onset epilepsy.
  • To identify risk factors associated with intractable epilepsy.
  • To provide insights from a decade-long follow-up in a tertiary center.

Main Methods:

  • Retrospective review of electronic medical records.
  • Inclusion criteria: epilepsy diagnosed before 12 months, >10 years follow-up.
  • Outcome assessment based on seizure freedom duration.

Main Results:

  • 146 patients analyzed; 70.5% achieved remission.
  • Epilepsy resolved in 31.5%; 33.6% had intractable epilepsy.
  • Delayed development, neurological deficits, and later onset (>3 months) linked to intractable cases (p < 0.01).

Conclusions:

  • Many infantile-onset epilepsy cases achieve seizure remission.
  • Early-onset epilepsy can be associated with comorbidities and intractable seizures.
  • Prompt diagnosis and treatment are vital to prevent neuropsychiatric complications.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
869
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
981
Long-term Potentiation01:25

Long-term Potentiation

Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Hebbian LTP
LTP can occur when...
3.1K
Long-term Potentiation01:35

Long-term Potentiation

Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre- and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
57.2K
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
430
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
951